Regrowing a full human tooth from nothing remains beyond what any dentist can offer today, but the science has progressed far enough that the first drug designed to trigger new tooth growth in people is approaching clinical trials. Research groups have identified the molecular brakes that prevent humans from growing a third set of teeth, engineered whole teeth that erupted in animal jaws, and already use limited regenerative procedures in dental clinics for certain young patients. The gap between lab results and a routine prescription is still wide, but it is narrowing in specific, measurable ways.
Why Humans Cannot Regrow Teeth in the First Place
Most vertebrates replace their teeth continuously throughout life. Sharks cycle through thousands. Crocodiles grow replacements as old teeth wear down. Even some mammals, like manatees, march new molars forward to replace worn ones. Humans, along with most other mammals, get two sets and that is it. A review of tooth replacement across species found that mammals have lost the capacity for continuous tooth renewal seen in most other vertebrates, typically developing only one to two generations of teeth.1PubMed Central. Biology of tooth replacement in amniotes
The evolutionary logic seems to involve a trade-off between tooth complexity and replaceability. Mammalian teeth are intricate structures with precise cusps, multiple roots, and enamel harder than bone, all shaped to interlock with the opposing jaw. That level of specialization apparently came at the cost of regenerative ability. The genetic programs for making replacement teeth did not vanish entirely, though. They were suppressed, and researchers have spent the last two decades figuring out what suppresses them and whether that suppression can be reversed.
What Sharks Reveal About the Regeneration Toolkit
Sharks have become a model organism for tooth regeneration research, not because anyone plans to give humans shark-like dentitions, but because they illuminate which genetic programs are needed. A study of catshark embryos found that several key signaling pathways involved in shark tooth development and regeneration are deeply conserved across roughly 450 million years of evolution.2PubMed. An ancient dental gene set governs development and continuous regeneration of teeth in sharks In plain terms, the genetic toolkit sharks use to keep making teeth is not alien to mammals. Humans have versions of those same genes. The difference lies in how they are regulated.
A particularly revealing finding came from studying a marker called Sox2, a gene associated with stem cells in many tissues. Researchers showed that Sox2-positive stem cells in sharks sit at a junction between taste buds and developing teeth. These cells migrate into deeper tissue layers where new teeth form, contributing directly to regeneration. Intriguingly, shark skin denticles, which are structurally similar to teeth, lack this Sox2 stem cell population and do not regenerate in the same continuous way.3PubMed Central. Sox2+ progenitors in sharks link taste development with the evolution of regenerative teeth from denticles The implication is that continuous tooth replacement requires a resident pool of stem cells, and the presence or absence of that pool is what separates regenerating teeth from non-regenerating ones.
The Molecular Brakes on Tooth Growth
Two signaling networks dominate tooth development: the Wnt pathway and the BMP (bone morphogenetic protein) pathway. Both are active during embryonic tooth formation in humans and mice, guiding where teeth initiate, how cusps form, and how roots develop.4PubMed Central. Role of the Wnt signaling molecules in the tooth These pathways do not just build teeth during development; Wnt signaling also participates in adult tooth maintenance and has therapeutic potential as a target for dental repair.5PubMed Central. Advances of Wnt signalling pathway in dental development and potential clinical application
The most clinically promising discovery involves a molecule called USAG-1 (uterine sensitization-associated gene-1). USAG-1 acts as a brake on both BMP and Wnt signaling. When researchers knocked out USAG-1 in mice, the animals developed extra teeth, suggesting that this molecule normally prevents additional teeth from forming even though the genetic instructions for making them still exist. A Japanese research team then developed antibodies that block USAG-1’s interaction with BMP specifically, without disrupting its effects on other pathways. In mice and ferrets, these antibodies accelerated tooth development and led to the formation of extra teeth.6PubMed Central. Anti-USAG-1 therapy for tooth regeneration through enhanced BMP signaling A review of this line of research concluded that USAG-1 inhibition has demonstrated potential to regenerate functional teeth, restore dental tissues, and address conditions where people are congenitally missing teeth.7PubMed Central. USAG‐1 and Regenerative Dentistry, Therapeutic Implications and Future Directions
Stem Cells as Building Material
Even if you can flip the right molecular switches, you need cells capable of building tooth tissues. Two main stem cell sources have shown promise: dental pulp stem cells harvested from existing teeth and induced pluripotent stem cells reprogrammed from ordinary adult cells.
Dental pulp stem cells (DPSCs) live inside the soft tissue at the center of your teeth. These cells can differentiate into multiple tissue types, and extensive research has confirmed their ability to produce dentin, the hard tissue that makes up most of a tooth’s structure.8PubMed Central. Dental Pulp Stem Cells: Advances to Applications Recent work has focused on boosting their regenerative output. One study found that activating a protein called YAP in DPSCs enhanced their proliferation, migration, and differentiation, with mineralization increasing by about a third. In living animals, DPSCs overexpressing YAP showed substantially higher production of dentin-specific markers.9PubMed Central. The Hippo-YAP/β-catenin signaling axis coordinates odontogenic differentiation in dental pulp stem cells
Induced pluripotent stem cells (iPSCs) offer a different route. Because they can be generated from a patient’s own skin or blood cells, they sidestep the problem of immune rejection. Researchers have shown that iPSC-derived cells, particularly neural crest cells and mesenchymal stem cells, can differentiate into the multiple cell types needed for tooth construction.10Japanese Dental Science Review. Dental applications of induced pluripotent stem cells and their derivatives One group reported a protocol that successfully differentiated iPSCs into both dental epithelial and dental mesenchymal cells capable of initiating the first stages of new tooth formation.11PubMed. Effective Differentiation of Induced Pluripotent Stem Cells Into Dental Cells Getting from “the first stages” to a fully formed, erupted tooth is a very large gap, but the proof of concept that reprogrammed cells can begin building tooth structures is significant.
Building Whole Teeth in the Lab
Two broad strategies exist for constructing teeth outside the body: growing them on scaffolds and assembling bioengineered tooth germs that develop naturally once transplanted.
On the scaffolds side, 3D-printed hydrogel structures made from materials like alginate and gelatin have been tested as frameworks for tooth tissue growth. One study found that 3D-printed scaffolds promoted the proliferation of dental pulp stem cells more effectively than conventionally prepared versions of the same material, and that cells grown on these scaffolds showed enhanced formation of bone-like mineralized nodules with increased expression of mineralization-related genes.12PubMed. Effects of 3-dimensional Bioprinting Alginate/Gelatin Hydrogel Scaffold Extract on Proliferation and Differentiation of Human Dental Pulp Stem Cells These scaffolds are still a long way from producing anything resembling a complete tooth, but they are useful for regenerating specific dental tissues like dentin or pulp.
The bioengineered tooth germ approach has produced more dramatic results. In a study using dogs, researchers created bioengineered tooth germs from cells harvested from permanent tooth buds and transplanted them into the jawbone. The bioengineered teeth developed correct tissue architecture, including enamel, dentin, cementum, and periodontal ligament, and erupted into the mouth about 180 days after transplantation.13Scientific Reports. Practical whole-tooth restoration utilizing autologous bioengineered tooth germ transplantation in a postnatal canine model This demonstrated that a lab-assembled cluster of the right cells, placed in the jaw, can self-organize into a functional tooth. The catch: the starting material was embryonic tooth germ tissue, which is not available in adult humans who have already grown all their teeth.
The Enamel Problem
Enamel is the hardest substance in the human body, and it is also the most stubbornly non-regenerative. The cells responsible for forming enamel, called ameloblasts, are lost through programmed cell death during tooth eruption. Once a tooth breaks through the gum, the enamel-making cells are gone for good. Mature human enamel is acellular and incapable of natural self-repair or regeneration after damage or disease.14PubMed Central. The REGENERATION of TOOTH ENAMEL
This creates a particular challenge for any regenerative strategy. Even if you can grow dentin, pulp, and root structures, coating the crown in genuine biological enamel requires either keeping ameloblasts alive long enough to finish the job or finding a synthetic substitute that matches enamel’s extreme hardness and organized crystal structure. Some researchers are pursuing biomimetic approaches that mimic enamel’s hydroxyapatite crystal formation using peptide gels or calcium-phosphate solutions, but none yet replicate the full thickness, hardness, and durability of natural enamel. The bioengineered teeth that erupted in dogs did form enamel, but they started from embryonic tooth germ tissue that still contained living ameloblast precursors. Replicating that in adult humans remains one of the field’s hardest unsolved problems.
Regenerative Procedures Already in Dental Clinics
While whole-tooth regeneration is still experimental, a limited form of dental regeneration is already used clinically. Regenerative endodontic procedures (REPs) are performed on immature permanent teeth, the kind seen in children and teenagers, that have lost their living pulp tissue due to infection or injury. Instead of performing a traditional root canal, the dentist disinfects the canal and then encourages the body’s own stem cells to repopulate the space, promoting continued root development.15PubMed Central. Expert consensus on regenerative endodontic procedures
The results are not full pulp regeneration in every case, but they can be clinically meaningful. Evidence suggests that cells from remnant pulp tissue or the root tip region can migrate into the disinfected canal space and deposit new hard tissue on the canal walls, increasing both root wall thickness and root length.16PubMed Central. Regenerative Endodontic Therapy in the Management of Nonvital Immature Permanent teeth REPs represent the current clinical frontier: genuine biological regeneration of dental tissues, limited to specific cases with immature roots, but real and in use.
An Antibody Drug Heading Toward Human Trials
The USAG-1 antibody work described earlier has moved beyond animal experiments. The research team behind it has finalized a protocol framework for a Phase 1 clinical study, and preparation for future human trials is underway.17PubMed. Development of a new antibody drug to treat congenital tooth agenesis The initial target is not regrowing teeth in people who lost them to cavities or trauma but treating congenital tooth agenesis, a condition where some permanent teeth never develop. Patients with this condition may retain dormant tooth buds that the antibody could activate.
This is a strategically smart starting point. People missing teeth from birth likely still harbor the rudimentary structures needed for tooth development, just arrested in an early stage. If the antibody can nudge those structures into completing development, the path to approval is more straightforward than trying to regenerate teeth from nothing. Whether the approach could eventually work for people who lost teeth to disease or injury, where no tooth bud remnant exists, is an open and much harder question.
Getting a New Tooth to Stay in the Jaw
Growing or triggering a tooth is only half the battle. A functional tooth needs to integrate with the surrounding bone, ligaments, nerves, and blood vessels. The periodontal ligament, a thin layer of connective tissue between the tooth root and the jawbone, is critical. It acts as a shock absorber, provides sensory feedback so you can feel how hard you are biting, and anchors the tooth in place.
Studies of replanted natural teeth offer insight into how fast this integration can happen. Research in dogs showed that periodontal fibers regenerated within one week of replantation, nerve fibers began regrowing from the root tip by two weeks, and by four weeks the vascular and neural elements of the periodontal ligament were almost fully restored, including mechanosensory receptors that detect bite pressure.18PubMed. Re-innervation in the canine periodontal ligament of replanted teeth using an antibody to protein gene product 9.5 A more recent study in rats confirmed a similar timeline, finding that molecular markers of nerve and blood vessel regrowth spiked around 15 days after replantation and returned to normal levels by 60 days, suggesting the healing process had completed.19PubMed. Investigation of the Mechanisms Involved in Periodontal Ligament Revascularization and Reinnervation Following Immediate Tooth Replantation in Rats
One complication is root resorption, where the body gradually absorbs the root of a replanted or transplanted tooth. An animal study found that normal biting forces actually protect against this. Teeth kept out of contact with opposing teeth showed significantly more root resorption and narrower periodontal ligament spaces compared with teeth that were allowed to function normally under occlusal force.20PubMed Central. Physiological occlusal force attenuates replacement root resorption of replanted teeth The practical takeaway for future regenerative therapies: a bioengineered tooth will need to be loaded mechanically, put to work chewing, relatively quickly to survive long-term.
Bio-Roots Versus Titanium Implants
The honest benchmark for any regenerated tooth is the titanium dental implant, which currently works extremely well. A head-to-head comparison in a miniature pig model tested bio-roots, built from stem cells and a ceramic scaffold, against conventional implants. Three months after crowns were placed, clinical assessments found that the bio-root functioned equivalently to the implant. The bio-root’s compressive strength and elasticity were closer to those of a natural tooth root than the implant’s were. But the success rate told a different story: implants succeeded in all nine cases, while bio-roots survived in only about one in five attempts.21PubMed. Bio-Root and Implant-Based Restoration as a Tooth Replacement Alternative
That 22% survival rate is the uncomfortable reality check for the field. A bio-root that works is biomechanically superior to an implant in some respects, behaving more like the natural structure it replaces. But a treatment that fails four out of five times is nowhere near clinical viability. The researchers themselves acknowledged that the tissue engineering procedures need substantial optimization. Until bio-roots or bioengineered teeth can approach the reliability of implants, they will remain experimental.
Gene Therapy and the “Third Dentition” Idea
A more speculative branch of regenerative dentistry explores whether gene therapy could stimulate what some researchers call a “third dentition,” essentially coaxing the jaw into producing a new round of teeth beyond the baby and adult sets. The concept relies on delivering genes that encode tooth-development signals directly to the jawbone. In vivo delivery, injecting gene vectors straight into the target site, has been considered the more feasible strategy because harvesting and reintroducing the right cell population is impractical given how few ideal cells are available.22IntechOpen. Feasibility of Gene Therapy for Tooth Regeneration by Stimulation of a Third Dentition
This approach faces steep challenges beyond the usual hurdles of gene therapy safety and delivery precision. Even if you could activate tooth formation genes in the adult jaw, there is no guarantee the resulting structure would form in the right location, at the right size, or with the right shape. Uncontrolled tooth growth in random positions would create more problems than it solves. The third-dentition concept illustrates both the ambition and the distance remaining: the genetic instructions for tooth-making are present in human tissue, but controlling their spatial and temporal activation in an adult jaw is an engineering problem that has not been cracked.
What a Realistic Timeline Looks Like
The field tends to generate exciting headlines, but the honest picture is layered. Regenerative endodontic procedures for immature teeth are already here and work. The USAG-1 antibody for congenital missing teeth is approaching Phase 1 trials, meaning the first human safety data could emerge within a few years, though efficacy trials and regulatory approval would follow on a longer timeline. Bioengineered whole teeth have been demonstrated in animals but face a steep climb in reliability and a complete absence of human data. Gene therapy for tooth regeneration is still largely conceptual.
For the average person who has lost a tooth to a cavity or a bad fall, titanium implants will remain the gold standard for the foreseeable future. The first clinical beneficiaries of regenerative approaches will likely be children born missing permanent teeth, a group for whom existing treatments are imperfect and who may still harbor the dormant biological structures that a drug could reactivate. From there, the technology could gradually expand its reach, but the leap from triggering a dormant tooth bud to growing a whole new tooth in an adult jaw with no bud remaining is qualitatively different and far harder. Anyone promising you a regrown molar by 2030 is selling hope ahead of evidence.